Alpha-carbolines for the treatment of cancer
US9428500B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 10, 2013 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | May 10, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/0812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I) as herein described and pharmaceutical compositions thereof, as well as to key intermediates towards their synthesis. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.